The majority of the US population has Covid antibodies, according to the CDC - here's what that means for you.

Concerns have been raised about a potential Covid surge due to the highly contagious BA.2 subvariant of the omicron variant.

It is unlikely that there will be a significant increase in Covid cases at present, according to experts, possibly due to a recent estimate that most Americans currently have some level of Covid antibodies.

An estimated 95% of Americans aged 16 and older have developed identifiable Covid antibodies, according to a Centers for Disease Control and Prevention survey of blood donor samples conducted in December and updated last month. These antibodies come from both vaccinations, with roughly 77% of the U.S. population having received at least one Covid vaccine dose, and prior Covid infections.

Even though BA.2 is currently the dominant Covid strain in the US and is surging in Europe, some experts, including White House chief medical advisor Dr. Anthony Fauci, do not anticipate a significant increase in cases at the moment.

While the antibody numbers indicate positive news, they do not guarantee that a surge will never occur. Antibodies are temporary, with some disappearing more quickly than others. Some of them do not aid your body in fighting the virus. Due to Covid's unpredictability, few projections can be fully relied upon.

Experts advise that in June 2021, before the peak of the delta variant in the U.S. in July, more than 87% of Americans had Covid antibodies.

Different types of immunity provide protection for different amounts of time

According to Dr. Timothy Brewer, a professor of medicine at the David Geffen School of Medicine at UCLA, the 95% estimate is likely to be accurate. However, there is a significant distinction between individuals who acquired their antibodies through Covid vaccines and those who did so solely through prior infections.

According to Brewer, antibodies from vaccinated individuals typically decrease after four to six months post-vaccination. Therefore, if you received a booster dose in December, your antibody boost is likely to expire between April and June.

The information about "natural immunity" is more complex and varied.

A study by the Yale School of Public Health, published in The Lancet Microbe in October 2021, found that unvaccinated individuals could have immunity against reinfection for a range of three to 61 months following a Covid-19 infection. However, the study's authors cautioned that more data is required to validate these findings, as their research did not account for variants such as omicron or subvariants like BA.2.

A study in Science published in January 2022 found that natural immunity can last up to eight months. Meanwhile, a CDC study from September 2021 revealed that about one-third of Covid patients did not show any signs of natural immunity.

Brewer states that he lacks knowledge about the length of antibodies resulting from a natural infection.

A study published in the National Library of Medicine last August found that unvaccinated individuals are more than twice as likely to get re-infected than those who got vaccinated after having Covid. Additionally, people who have recovered from an omicron infection may have better protection from BA.2 than those who recovered from other Covid variants or were last vaccinated more than four to six months ago, according to Brewer.

Nonetheless, a prior illness or immunization continues to safeguard against severe illness and mortality, as he asserts.

Not all antibodies are ‘Covid-fighting’ antibodies

According to Dr. Salman Khan, an infectious disease specialist at Lenox Hill Hospital in New York City, while most people in the U.S. have antibodies against Covid, not all of these are "Covid-fighting" or neutralizing antibodies.

Khan explains that sometimes, non-neutralizing antibodies are produced in response to a pathogen. These antibodies do not bind sufficiently to the specific site on the pathogen to stop it from continuing to cause infection. In the case of SARS-CoV-2, mutations to the spike protein may be the reason for this.

Non-neutralizing antibodies function "almost like a GPS," says Hannah Newman, Lenox Hill Hospital's director of infection prevention. They still attach themselves to the virus, but instead of working to stop the pathogen from spreading, they "serve as a locator, indicating to other parts of the immune system that there is a problem," Newman explains.

While both types of antibodies are beneficial, a positive Covid antibody test does not necessarily mean your body can fight off a future Covid infection.

Nobody knows what the future holds

According to John P. Moore, a professor of microbiology and immunology at Cornell University's Weill Cornell Medicine, the Covid pandemic teaches us that no one can accurately predict the future.

Moore states that because individuals desire to believe the pandemic has ended, they become less cautious in their behavior, but the future remains uncertain as nobody can predict what will occur tomorrow, next week, or next month.

According to Johns Hopkins University data, the seven-day average of daily new U.S. cases as of Monday is 30,662. Although this is relatively low compared to pandemic standards, it is uncertain whether this trend is sustainable or merely a temporary fluctuation, as stated by Moore.

Moore emphasizes that the CDC's antibodies statistic is only an estimate, as it is based on blood donors and does not include individuals under the age of 16. He questions the representativeness of blood donors in the general population.

Moore advises that individuals should monitor their perception of risk and make Covid-related decisions based on their own lives and circumstances, rather than suggesting that everyone must remain indoors.

The BA.2 subvariant of omicron has recently become the dominant Covid strain in the United States.

Don’t miss: